From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 11,254,007 shares, representing 7.51% for $2,950 million under the buyback announced on October 21, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221.5 USD | -0.56% | +1.83% | -14.40% |
May. 09 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
May. 08 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.40% | 32.25B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B | |
-3.16% | 8.62B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Tranche Update on Biogen Inc.'s Equity Buyback Plan announced on October 21, 2020.